Cheng Yi, Ph.D. - Publications

Affiliations: 
2014 Computer Science University of Arizona, Tucson, AZ 
Area:
Computer Science, Computer Engineering

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gao L, Yang X, Yi C, Zhu H. Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review. Frontiers in Pharmacology. 10: 1173. PMID 31680957 DOI: 10.3389/fphar.2019.01173  0.32
2019 Liu J, Yi C, Zhu H, Ma H. Property Comparison of Alkali-Activated Carbon Steel Slag (CSS) and Stainless Steel Slag (SSS) and Role of Blast Furnace Slag (BFS) Chemical Composition. Materials (Basel, Switzerland). 12. PMID 31614483 DOI: 10.3390/ma12203307  0.32
2019 Zhao Y, Yi C, Zhang Y, Fang F, Faramand A. Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials. Plos One. 14: e0220533. PMID 31361784 DOI: 10.1371/journal.pone.0220533  0.32
2019 Ma H, Zhu H, Yi C, Fan J, Chen H, Xu X, Wang T. Preparation and Reaction Mechanism Characterization of Alkali-activated Coal Gangue-Slag Materials. Materials (Basel, Switzerland). 12. PMID 31336925 DOI: 10.3390/ma12142250  0.32
2019 Zhu H, Yang X, Zhao Y, Yi C. Efficacy of anti-PD-1 antibody SHR-1210 as second-line treatment in hepatocellular carcinoma patient with sorafenib resistance: A case report. Medicine. 98: e15755. PMID 31096541 DOI: 10.1097/MD.0000000000015755  0.32
2019 Zhu H, Zhang C, Yang X, Yi C. Treatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma: A case report. Medicine. 98: e14823. PMID 30855507 DOI: 10.1097/MD.0000000000014823  0.32
2019 Chen Y, Wu J, Cheng K, Li ZP, Luo DY, Qiu M, Gou HF, Yi C, Li Q, Wang X, Yang Y, Cao D, Shen YL, Bi F, Liu JY. S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial. The Oncologist. PMID 30651398 DOI: 10.1634/theoncologist.2018-0901  0.48
2018 Zhu H, Yi C, Zhao Y, Gou H. Gemcitabine plus S-1 for metastatic pancreatic cancer. Medicine. 97: e12836. PMID 30313120 DOI: 10.1097/MD.0000000000012836  0.32
2018 Huang M, Zhu H, Yi C, Yan J, Wei L, Yang X, Chen S, Huang Y. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer. Cancer Chemotherapy and Pharmacology. PMID 30167846 DOI: 10.1007/s00280-018-3658-9  0.32
2017 Zhu H, Yan J, Xu Q, Wei L, Huang X, Chen S, Yi C. TRAIL mutant membrane penetrating peptide alike (TMPPA) TRAIL‑Mu3 enhances the antitumor effects of TRAIL in vitro and in vivo. Molecular Medicine Reports. PMID 29039511 DOI: 10.3892/mmr.2017.7791  0.32
2017 Zhu A, Wang X, Huang M, Chen C, Yan J, Xu Q, Wei L, Huang X, Zhu H, Yi C. Generation of a novel TRAIL mutant by proline to arginine substitution based on codon bias and its antitumor effects. Molecular Medicine Reports. PMID 28791342 DOI: 10.3892/mmr.2017.7146  0.48
2017 Gao L, Wang L, Sun Z, Li H, Wang Q, Yi C, Wang X. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition. Drug Design, Development and Therapy. 11: 1789-1802. PMID 28670112 DOI: 10.2147/DDDT.S138320  0.48
2017 Sun L, Chen C, Zhu A, Huang Y, Zhu H, Yi C. TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo. International Journal of Molecular Medicine. PMID 28487979 DOI: 10.3892/ijmm.2017.2968  0.32
2015 Shu P, Shen Y, Zhao Y, Xu F, Qiu M, Li Q, Gou H, Cao D, Yang Y, Liu J, Yi C, Liao Z, Luo D, Bi F, Wang X, et al. A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors. Medical Oncology (Northwood, London, England). 32: 247. PMID 26433959 DOI: 10.1007/s12032-015-0689-5  0.48
2015 Qiu M, Peng XC, Bi F, Wang X, Li Q, Xu F, Li ZP, Shen YL, Liu JY, Zhao YQ, Cao D, Gou HF, Yang Y, Chen Y, Yi C. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer. Medical Oncology (Northwood, London, England). 32: 191. PMID 26025485 DOI: 10.1007/s12032-015-0635-6  0.48
2015 Wang X, Shen Y, Zhu H, Zhao Y, Li Z, Qiu M, Li Q, Gou H, Yang Y, Cao D, Liu J, Yi C, Liao Z, Luo D, Bi F, et al. A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 25609451 DOI: 10.1007/s10120-015-0461-8  0.48
2015 Shi X, Yi C, Wang X, Zhang B, Chen Z, Tang G, Zhang X. 13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess. Clinical Nuclear Medicine. 40: 195-9. PMID 25546194 DOI: 10.1097/RLU.0000000000000649  0.48
2015 Luo J, Zhang Y, Hu X, Zhong S, Chen G, Wang Y, Lin W, Yi C, Zhu H. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats. Journal of Ethnopharmacology. 161: 53-9. PMID 25499312 DOI: 10.1016/j.jep.2014.12.003  0.32
2014 Zhao F, Cao Y, Zhu H, Huang M, Yi C, Huang Y. The -765G>C polymorphism in the cyclooxygenase-2 gene and digestive system cancer: a meta-analysis. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 8301-10. PMID 25339021  0.32
2014 Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang L, Wang X, Wang C, Huo X, Yu W, Yi C, Xiao Y, Yang W, Qin Y, Yuan Y, et al. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Molecular Cancer. 13: 203. PMID 25175164 DOI: 10.1186/1476-4598-13-203  0.48
2014 Yi C, Shi X, Wang X, Chen Z, Zhang B, Zhang X. The alteration of 18F-FDG uptake in bone marrow after treatment with interleukin 11. Clinical Nuclear Medicine. 39: 934-5. PMID 25036016 DOI: 10.1097/RLU.0000000000000491  0.48
2014 Yu L, Wang Y, Yao Y, Li W, Lai Q, Li J, Zhou Y, Kang T, Xie Y, Wu Y, Chen X, Yi C, Gou L, Yang J. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 1158-64. PMID 24987913 DOI: 10.1097/IGC.0000000000000179  0.32
2014 Zhao F, Zhu H, Huang M, Yi C, Huang Y. The 765G>C polymorphism in the cyclooxygenase-2 gene and gastric cancer risk: an update by meta-analysis. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 2863-8. PMID 24761915  0.32
2014 Wang X, Shi X, Yi C, Chen Z, Zhang B, Zhang X. Hepatic tuberculosis mimics metastasis revealed by 18F-FDG PET/CT. Clinical Nuclear Medicine. 39: e325-7. PMID 24152632 DOI: 10.1097/RLU.0000000000000263  0.48
2014 Wang W, Yi C. Molecular dynamics understanding on tensile behaviours of cold welding experiments of <100>. oriented ultra-thin gold nanowires Materials Research Innovations. 18: S2673-S2677. DOI: 10.1179/1432891714Z.000000000540  0.96
2013 Shi X, Liu Y, Zhang X, Yi C, Wang X, Chen Z, Zhang B. The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas. Clinical Nuclear Medicine. 38: 522-6. PMID 23698463 DOI: 10.1097/RLU.0b013e318295298d  0.48
2013 Shi X, Zhang X, Yi C, Wang X, Chen Z, Zhang B. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients. Clinical Nuclear Medicine. 38: 98-102. PMID 23334122 DOI: 10.1097/RLU.0b013e318279b6cc  0.48
2013 Xu X, Yi C. The influence of geometry on recirculation and CO2 transport over forested hills Meteorology and Atmospheric Physics. 119: 187-196. DOI: 10.1007/s00703-012-0224-6  1
2012 Wang W, Yi C. A new nonlinear analytical model for canopy flow over a forested hill Theoretical and Applied Climatology. 109: 549-563. DOI: 10.1007/s00704-012-0599-9  1
2011 Zhang Y, Yi C. Zhang neural networks and neural-dynamic method Zhang Neural Networks and Neural-Dynamic Method. 1-261.  0.32
2010 Yi C, Wang W. On the connectivity analysis over large-scale hybrid wireless networks Proceedings - Ieee Infocom. DOI: 10.1109/INFCOM.2010.5462106  1
2009 Yi C. Instability analysis of terrain-induced canopy flows Journal of the Atmospheric Sciences. 66: 2134-2142. DOI: 10.1175/2009JAS3005.1  1
2008 Yi C. Momentum transfer within canopies Journal of Applied Meteorology and Climatology. 47: 262-275. DOI: 10.1175/2007JAMC1667.1  1
2008 Yi C, Zhang Y. Analogue recurrent neural network for linear algebraic equation solving Electronics Letters. 44: 1078-1080. DOI: 10.1049/el:20081390  0.32
Show low-probability matches.